In addition, AR2.5 internalization is achieved via dendritic cells (DCs), thus facilitating efficient MUC1 antigen processing, cross-presentation to T-cells, and the later activation of cytotoxic T-cells for eradicating cancer cells [99]. The gene discussed is MUC1; the disease is cancer.